Know Cancer

or
forgot password

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting


N/A
18 Years
75 Years
Not Enrolling
Both
Hepatitis B Virus, Allograft, Hematological Malignancies

Thank you

Trial Information

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting


Inclusion Criteria:



- All patients undergoing an allograft for hematological malignancies

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Authority:

Italy: Ministry of Health

Study ID:

LAM Allo SCT

NCT ID:

NCT00876148

Start Date:

Completion Date:

Related Keywords:

  • Hepatitis B Virus
  • Allograft
  • Hematological Malignancies
  • Incidence of hepatitis B after allografting
  • Risk of hepatitis B reactivation
  • Lamivudine prophylaxis
  • Neoplasms
  • Hepatitis
  • Hepatitis A
  • Hepatitis B
  • Virus Diseases
  • Hematologic Neoplasms

Name

Location